Acceptability of HIV Pre-exposure Prophylaxis (PREP) Among People Who Inject Drugs (PWID) in a Canadian Setting.
about
Substance-use and sexual harm reduction strategies of methamphetamine-using men who have sex with men and inject drugs.Complex and Conflicting Social Norms: Implications for Implementation of Future HIV Pre-Exposure Prophylaxis (PrEP) Interventions in Vancouver, Canada.Values and Preferences on the Use of Oral Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Multiple Populations: A Systematic Review of the Literature.High Willingness to Use HIV Pre-Exposure Prophylaxis Among Transgender Women in Argentina.Improving the effectiveness and delivery of pre-exposure prophylaxis (PrEP) to people who inject drugs.Primary Care Physicians' Willingness to Prescribe HIV Pre-exposure Prophylaxis for People who Inject Drugs.HIV providers' likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: a short report.'PrEP is not ready for our community, and our community is not ready for PrEP': pre-exposure prophylaxis for HIV for people who inject drugs and limits to the HIV prevention response.Temporal Fluctuations in Behavior, Perceived HIV Risk, and Willingness to Use Pre-Exposure Prophylaxis (PrEP).Expanding the Menu of HIV Prevention Options: A Qualitative Study of Experiences with Long-Acting Injectable Cabotegravir as PrEP in the Context of a Phase II Trial in the United States.Exploring acceptability of oral PrEP prior to implementation among female sex workers in South Africa.Evolving Models and Ongoing Challenges for HIV Preexposure Prophylaxis Implementation in the United States.HIV Risk perception and eligibility for pre-exposure prophylaxis in women involved in the criminal justice system.Oral Pre-Exposure Prophylaxis (PrEP) for HIV Prevention in Adolescents and Young Adults
P2860
Q35587333-84D9FC29-9971-4C45-BE8D-23AF9808C3C1Q35891499-AF6C640D-F814-45B9-AE90-5D751F2B9ED6Q37736077-D360CEBB-4AC2-43A6-9960-03D38A369C90Q38598467-BD53FA29-50B9-4708-BAA4-DE850447AAE6Q40412012-E2234801-1EC7-47B5-B2D9-F674485780A2Q40431814-4B697C63-CF77-4E9A-B43B-61193DCD83BFQ40777604-CE8EC0AB-EFAF-45C4-B44B-A93230778C13Q42104687-3A48F6CB-26BF-4662-87CB-C908641D564DQ47556658-76485C9B-C420-439D-AC6C-B576DFBA482BQ49382513-48342ED9-5EB2-4084-B125-0CFB5866DB3CQ49850256-B95F133F-7DA9-4E7F-9ADD-F1062DFB1946Q50224009-F752AB1D-C1C7-4D99-8AE3-81757160A285Q52661345-192CF37C-7896-4F7D-A005-FBAB73FCFF89Q57825304-8D8FDAED-98F0-4506-9A13-AC79BAE50EA4
P2860
Acceptability of HIV Pre-exposure Prophylaxis (PREP) Among People Who Inject Drugs (PWID) in a Canadian Setting.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Acceptability of HIV Pre-expos ...... (PWID) in a Canadian Setting.
@en
type
label
Acceptability of HIV Pre-expos ...... (PWID) in a Canadian Setting.
@en
prefLabel
Acceptability of HIV Pre-expos ...... (PWID) in a Canadian Setting.
@en
P2093
P2860
P50
P1433
P1476
Acceptability of HIV Pre-expos ...... (PWID) in a Canadian Setting.
@en
P2093
Brandon D L Marshall
Daniel J Escudero
Paul Nguyen
P2860
P2888
P304
P356
10.1007/S10461-014-0867-Z
P577
2015-05-01T00:00:00Z